Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy STAAR Surgical Company stock (STAA)

Buy STAAR Surgical Company stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

STAAR Surgical Company is a medical instruments & supplies business based in the US. STAAR Surgical Company shares (STAA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $24.21 – a decrease of 2.46% over the previous week. STAAR Surgical Company employs 1,056 staff and has a trailing 12-month revenue of around $341.2 million.

Our top picks for where to buy STAAR Surgical Company stock

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%

How to buy STAAR Surgical Company stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – STAA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy STAAR Surgical Company stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 4 of 4
Product USFST Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Finder score
Stocks, ETFs
$0
$0
N/A
Earn up to $300
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.35%
Get up to $10,000 and transfer fees covered
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

STAAR Surgical Company stock price (NASDAQ: STAA)

Use our graph to track the performance of STAA stocks over time.

STAAR Surgical Company shares at a glance

Information last updated 2024-12-26.
Latest market close$24.21
52-week range$23.72 - $52.68
50-day moving average $27.93
200-day moving average $36.86
Wall St. target price$41.89
PE ratio 56.75
Dividend yield N/A
Earnings per share (TTM) $0.44

Is it a good time to buy STAAR Surgical Company stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

STAAR Surgical Company price performance over time

Historical closes compared with the close of $24.21 from 2024-12-27

1 week (2024-12-20) -2.46%
1 month (2024-11-29) -16.80%
3 months (2024-09-27) -34.97%
6 months (2024-06-28) -49.15%
1 year (2023-12-28) -24.58%
2 years (2022-12-28) -48.29%
3 years (2021-12-28) 91.16
5 years (2019-12-27) 36.5

Is STAAR Surgical Company stock undervalued or overvalued?

Valuing STAAR Surgical Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of STAAR Surgical Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

STAAR Surgical Company's P/E ratio

STAAR Surgical Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 57x. In other words, STAAR Surgical Company shares trade at around 57x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

STAAR Surgical Company's EBITDA

STAAR Surgical Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $33.1 million.

The EBITDA is a measure of a STAAR Surgical Company's overall financial performance and is widely used to measure a its profitability.

STAAR Surgical Company financials

Revenue TTM $341.2 million
Operating margin TTM 6.49%
Gross profit TTM $223.4 million
Return on assets TTM 3.39%
Return on equity TTM 5.4%
Profit margin 6.38%
Book value $8.69
Market Capitalization $1.2 billion

TTM: trailing 12 months

STAAR Surgical Company share dividends

We're not expecting STAAR Surgical Company to pay a dividend over the next 12 months.

Have STAAR Surgical Company's shares ever split?

STAAR Surgical Company's shares were split on a 1:2 basis on 17 May 1992 . So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your STAAR Surgical Company shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for STAAR Surgical Company shares which in turn could have impacted STAAR Surgical Company's share price.

STAAR Surgical Company share price volatility

Over the last 12 months, STAAR Surgical Company's shares have ranged in value from as little as $23.72 up to $52.68. A popular way to gauge a stock's volatility is its "beta".

STAA.US volatility(beta: 0.62)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while STAAR Surgical Company's is 0.615. This would suggest that STAAR Surgical Company's shares are less volatile than average (for this exchange).

STAAR Surgical Company overview

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California. .

Frequently asked questions

What percentage of STAAR Surgical Company is owned by insiders or institutions?
Currently 0.531% of STAAR Surgical Company shares are held by insiders and 99.261% by institutions.
How many people work for STAAR Surgical Company?
Latest data suggests 1,056 work at STAAR Surgical Company.
When does the fiscal year end for STAAR Surgical Company?
STAAR Surgical Company's fiscal year ends in December.
Where is STAAR Surgical Company based?
STAAR Surgical Company's address is: 25651 Atlantic Ocean Drive, Lake Forest, CA, United States, 92630
What is STAAR Surgical Company's ISIN number?
STAAR Surgical Company's international securities identification number is: US8523123052
What is STAAR Surgical Company's CUSIP number?
STAAR Surgical Company's Committee on Uniform Securities Identification Procedures number is: 852312305

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site